Media Thread, page-17325

Found this link while doing some research, published jan this year. A bit shocked when i read the following paragraph.

Another technique being pursued is to immunize patients with a viral vector which trains the immune system to act against p53 epitopes. At City of Hope, a clinical trial was started to immunize patients who have ovarian cancer with a vaccinia virus vector against p53 epitopes, e.g., p53 MVA. No results have been published from this clinical trial yet, though it has been theorized that the B-cell adaptive immune response triggered by this approach may not be sufficient to inhibit tumor growth (Levine, 2020b; Levine,

2020a).https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1529483/full

Not sure if it is speaking specifically about ovarian cancer and if it is relevant but, just makes me nervous, the first positive news about azercell and the company was screaming from the roof tops, they have been forward and vocal on every other positive outcome.

It makes me uncomfortable to read negative feedback published respected scientific journals. Add this to their unwillingness to release data and i feel we have a legitimate cause for concern despite what the "pumpers" sprout.